Our study showed that it is mandatory to consider the complex interplay between the type of BRCA1 and BRCA2 pathogenic variants, age at primary breast cancer diagnosis, breast cancer subtype and stage, and systemic treatment received. The gene discussed is BRCA2; the disease is breast carcinoma.